For: | Jin G, Hu XG, Ying K, Tang Y, Liu R, Zhang YJ, Jing ZP, Xie Y, Mao YM. Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays. World J Gastroenterol 2005; 11(41): 6543-6548 [PMID: 16425432 DOI: 10.3748/wjg.v11.i41.6543] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i41/6543.htm |
Number | Citing Articles |
1 |
Nikolina Radulovich, Nhu-An Pham, Dan Strumpf, Lisa Leung, Wing Xie, Igor Jurisica, Ming-Sound Tsao. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Molecular Cancer 2010; 9(1) doi: 10.1186/1476-4598-9-24
|
2 |
Thomas M. Gress, Hans A. Kestler, Ludwig Lausser, Lisa Fiedler, Bence Sipos, Christoph W. Michalski, Jens Werner, Nathalia Giese, Aldo Scarpa, Malte Buchholz. Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens. Journal of Molecular Medicine 2012; 90(4): 457 doi: 10.1007/s00109-011-0832-5
|
3 |
|
4 |
Kevin McLoughlin, Ken Turteltaub, Danute Bankaitis-Davis, Richard Gerren, Lisa Siconolfi, Kathleen Storm, John Cheronis, David Trollinger, Dennis Macejak, Victor Tryon, Michael Bevilacqua. Limited Dynamic Range of Immune Response Gene Expression Observed in Healthy Blood Donors Using RT-PCR. Molecular Medicine 2006; 12(7-8): 185 doi: 10.2119/2006-00018.McLoughlin
|
5 |
Malte Buchholz, Thomas M Gress. Molecular changes in pancreatic cancer. Expert Review of Anticancer Therapy 2009; 9(10): 1487 doi: 10.1586/era.09.107
|
6 |
Mark J Truty, Raul Urrutia. Applications of microarray technology to pancreatic cancer research and drug development. Expert Opinion on Drug Discovery 2006; 1(5): 447 doi: 10.1517/17460441.1.5.447
|
7 |
Malte Buchholz, Hans Kestler, Thomas M. Gress. Differential Diagnosis of Pancreatic Tumors by Molecular Analysis of Clinical Specimens. Pancreatology 2008; 8(6): 551 doi: 10.1159/000159213
|
8 |
Maria Vila-Casadesús, Elena Vila-Navarro, Giulia Raimondi, Cristina Fillat, Antoni Castells, Juan José Lozano, Meritxell Gironella. Deciphering microRNA targets in pancreatic cancer using miRComb R package. Oncotarget 2018; 9(5): 6499 doi: 10.18632/oncotarget.24034
|
9 |
Bin Zhong, Dan-Dan Ma, Tao Zhang, Qi Gong, Yi Dong, Jian-Xin Zhang, Zhong-Hu Li, Wei-Dong Jin. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell
Function of Tropomodulin-3 in Pancreatic Adenocarcinoma. Combinatorial Chemistry & High Throughput Screening 2024; 27(7): 1011 doi: 10.2174/1386207326666230810142646
|
10 |
Carmen García-Pravia, José A. Galván, Natalia Gutiérrez-Corral, Lorena Solar-García, Eva García-Pérez, Marcos García-Ocaña, Jokin Del Amo-Iribarren, Primitiva Menéndez-Rodríguez, Juan García-García, Juan R. de los Toyos, Laureano Simón-Buela, Luis Barneo, Francisco X. Real. Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer. PLoS ONE 2013; 8(10): e78327 doi: 10.1371/journal.pone.0078327
|
11 |
Pallavi Chaturvedi, Ajay P. Singh, Nicolas Moniaux, Shantibhushan Senapati, Subhankar Chakraborty, Jane L. Meza, Surinder K. Batra. MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins. Molecular Cancer Research 2007; 5(4): 309 doi: 10.1158/1541-7786.MCR-06-0353
|